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ABSTRACT 
 
It is widely known that human immunodeficiency virus type-1 (HIV-1) can cause 
acquired immune deficiency syndrome (AIDS), but treatments to prevent the virus from 
escalating to that severity have come a long way since the virus was first described in the 1980s. 
The medications, combined antiretroviral therapy (cART), keep the virus from replicating, thus 
stopping its progression to AIDS. However, this treatment does not seem to ultimately benefit 
the brain, in part because cART does not uniformly penetrate the blood-brain barrier (BBB), and 
in part because HIV-1 seems to permanently turn on the part of the immune system that causes 
neuroinflammation. This allows the virus to exist in white blood cells and brain-resident glia 
amongst the neurons, wreaking havoc on the body's central nervous system (CNS). Harris 
Gelbard and his research laboratory aim to understand the molecules and pathways involved in 
neuroinflammation caused by HIV-1 and the resulting HIV-associated neurocognitive disorders 
(HAND). The lab's research has revealed several of the key components of this disease's 
progression and has even synthesized small molecules with drug-like properties that confer 
neuroprotection in models of HAND. Applications of these molecules in a pharmaceutical 
setting and its delivery method for humans have yet to be established. The artwork created for 
this Thesis will visualize some of the research through illustrations, an animation, and an 
interactive game. The artwork will be effective in communicating the complexity of the research 
with graphical representations due to the collaboration with and contributions from the members 
of the Gelbard laboratory. 
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INTRODUCTION 
 The debate continues as to whether or not viruses can be considered living organisms; 
they have genetic material, but they lack organelles and the machinery to self-replicate. They can 
spread from cell to cell, and the best medications only prevent the viruses from replicating. The 
best advice doctors can give during an influenza virus infection is to 'wait it out'. How can 
something that acts like it is alive, not be alive, and simultaneously cause so much destruction? 
HIV, in particular, is a virus that has been in the United States since the 1980s and is still not 
completely understood. The medications available keep the viral infection from progressing into 
a much worse syndrome, but not from destroying the cells that they infect. The viruses' relentless 
ability to reproduce and destroy the balance between the host’s immune and nervous systems, 
even though it isn't a living organism, is still a mystery of nature. 
The medical importance of this project stems directly from the work of Dr. Harris 
Gelbard and the members of the Gelbard laboratory; their research aims to understand the 
molecules and pathways involved in neuroinflammation caused by HIV-1 and the resulting HIV-
associated neurocognitive disorders (HAND). The Thesis itself is a medium for the lab to 
communicate their research to the public. The laboratory is very prolific in producing papers 
explaining their research, but visual media that would translate some of their data would 
definitely help summarize the information in a format that would be more available for public 
consumption. Hopefully, raising awareness of this subject and educating other labs with the 
current research will help the scientific community get closer to a cure. Neuroinflammation and 
resulting neurocognitive disorders are what happen in the background of HIV 'suppression', so 
answers must be found. 
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WHAT IS HIV? 
HIV, or human immunodeficiency virus, is a retrovirus that was first recognized in the 
United States in 1981. Originally thought to only be sexually transmitted, evidence of HIV cases 
became frequent in patients who were "intravenous drug users, blood transfusion recipients, and 
infants born to infected mothers" (Porth, 428). Therefore, the virus could be spread by blood and 
from mother to infant. Despite HIV's recent appearance, it has reached "epidemic proportions, 
with around 33 million people infected worldwide" (Parham, 25), according to a 2007 figure by 
the UNAIDS/World Health Organization. In 2007 in North America alone, there were 1.3 
million HIV infected individuals (46,000 of those cases were new that year), and 21,000 deaths 
(Parham, 25). 
Protein synthesis in cells normally occurs in one direction: DNA is unzipped, a 
complimentary RNA strand is created, and cellular machinery constructs a protein strand from 
raw materials (amino acids) by following the RNA code. HIV is a retrovirus and, as the name 
implies, directs its protein synthesis in a backwards (retro-) direction. After the lipid envelope of 
the virus fuses with the host cell, the virus genome enters the host cell and a complimentary 
strand of DNA is created. This new DNA integrates into the host cell's DNA and the process of 
canonical protein synthesis occurs, but the end products are used to construct more viruses 
(Parham, 352). When "infecting a human cell, HIV recruits 273 human proteins to serve its own 
purpose" (Parham, 352). 
The anatomy of the virus is more clever than it is original. The lipid envelope that 
surrounds the virus is made of a few components. For starters, the lipids are stolen as the virus 
buds from the host cell. Surface proteins on the lipid envelope include gp120 and gp41, where 
the gp- is for glycoprotein. These markers are important for receptor binding and fusion with 
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human cells; gp120 binds to CD4 on T-cells, which triggers the release of gp41, which helps the 
envelope fuse with the host cell membrane. The nucleocapsid is within the lipid envelope and 
surrounds the virus's RNA genome and proteins that direct the genome's transcription (Parham, 
351). Although HIV-1 Tat protein is not included in the nucleocapsid, it is one of the first 
proteins encoded from the original genome. The importance of HIV-1 Tat protein will be 
explained later. 
Once the virus enters an individual's body, the virus can devastate the immune system by 
infecting and destroying immune cells; T cells (i.e. CDa lymphocytes) in particular. After the 
initial infection period of two to six weeks, the patient enters a clinical latency period of up to 
fifteen years. During the latency, or asymptomatic period, the virus continues its conquest over 
the patient's immune system. As the immune system fails, opportunistic infections that are 
normally held in check by host immune defenses become clinically evident put more stress on 
the immune system. Together, the infections lower the T-cell count from an average >1000 T-
cells/µL that left unchecked can drop to 0 T-cells/µL. When the number drops below 200 T-
cells/µL, the patient has developed AIDS, or acquired immune deficiency syndrome (Parham, 
354). 
Even though there is no cure for the infection, there are means of controlling it "to slow 
the progression [of the disease] to AIDS" (Porth 441). "The first drug that was approved by the 
FDA for the treatment of HIV was zidovudine [an antiretroviral drug] in 1987" (Porth, 441). 
Zidovudine is still prescribed to pregnant mothers to prevent the transmission of the virus to the 
developing child (Parham, 358). However, instead of one medication being prescribed, 
combination therapy is used to target a population of viruses that may differ from one another in 
adult individuals. In general, combined antiretroviral therapy (cART) is the combination of 
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drugs that interfere with different stages of a virus’s replication cycle; the goal, in this case, is to 
prevent the HIV infection from progressing to AIDS. "The goal of HAART [i.e. cART] is 
sustained suppression of HIV replication, resulting in an undetectable viral load and increasing 
[T] cell count" (Porth, 441). Unfortunately, the drugs and body's defenses can only slow down 
the virus's progression, but not terminate it. "HIV and other retroviruses have high mutation rates 
because their reverse transcriptases lack proofreading" (Parham, 357), thus increasing the chance 
of a mutation to become resistant to drugs and immune system defenses. Despite the success that 
an individual might be experiencing with the antiretroviral medications, penetration of the drug 
through the blood-brain barrier is limited, leading to progression of neurologic disease in the 
brain (Vetrivel, 44). 
 
WHAT ARE NEUROCOGNITIVE DISORDERS? 
In order to understand the implications of HIV infections in the brain, a brief description 
of the cells involved is necessary. Cells of the central nervous system (CNS) are either neurons 
or neuroglia. Important neuroglia involved in this discussion are astrocytes and microglia. 
Aside from the many functions astrocytes have, for the purposes of this discussion, the only 
relevant one noting is their role in the formation of the blood-brain barrier (BBB) (Sherwood, 
137). Microglia are the resident immune cells of the brain; when they are in their ‘quiescent’ 
state (actually a misconception, since they constantly patrol neuronal synaptic architecture and 
function), they extend projections between cells to monitor the area for antigens. Once an antigen 
is detected, the microglia goes through a morphological change into an ameboid shape, rolls 
towards the foreign substance, and destroys it (Sherwood, 138). "Microglia are derived from the 
same bone-marrow tissue that gives rise to monocytes. During embryonic development, 
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microglia migrate to the CNS, where they remain stationary [i.e. relative to their local micro-
environment in a brain region] until activated by an infection" (Sherwood, 138). The important 
leukocytes, or white blood cells, are T-cells and macrophages; both are attracted to the inflamed 
brain when microglia release cytokines and enter as the BBB becomes more permeable. 
HIV enters the brain by infecting infiltrating leukocytes. This Trojan horse approach 
allows the virus to enter, without any interference from the blood-brain barrier. Once inside, the 
virus is free to productively (i.e. make copies of itself) infect microglia and macrophages around 
blood vessels, or perivascular macrophages and astrocytes (where the infection is restricted to 
secretion of regulatory gene products like Tat). The virus does not infect neurons or other 
specialized glia like oligodendrocytes, but the work here is focused on the unique set of 
relationships between neurons, microglia, and macrophages. 
Neurocognitive disorders occur because of an HIV infection in the brain. When 
microglia come into contact with HIV, they become activated and destroy the infected cells, as 
expected. Unfortunately, "excessive release of chemicals from overzealous microglia may 
damage the neurons they are meant to protect" (Sherwood, 138). The disorder progresses when 
microglia phagocytose not only damaged or dysfunctional synapses, but also normal synapses 
between neurons in the brain. The loss of connections between neurons results in a loss of 
communication and memory. This degenerative condition leads to the collection of disorders 
called neurocognitive disorders. 
"Even with stringent adherence to anti-retroviral therapy, >50% of patients living with 
HIV-1 will develop HAND [HIV-associated neurocognitive disorders]" (Marker et al., 9998). 
Resulting neurocognitive disorders from synapse destruction include: 
• HIV-1-associated dementia 
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• HIV-1-associated mild neurocognitive disorder 
• HIV-1 associated asymptomatic neurocognitive impairment 
 
DR. HARRIS A. GELBARD’S RESEARCH 
Dr. Harris Gelbard and his laboratory, in the Center for Neural Development and Disease 
at the University of Rochester Medical Center, aim to understand the cellular and molecular 
pathways that are involved in the pathophysiology of the disease. Gelbard and his laboratory 
members use HIV-1 Tat [transactivator of transcription] protein to activate cells in the brains of 
mice. "[The lab] elected to investigate the effects of acute hippocampal exposure to HIV-1 Tat 
because a large body of literature using both rats and mice has demonstrated robust Tat-
associated changes in synaptic architecture in this brain region as well as behavioral 
consequences" (Lu et. al., 2). 
Among the research being conducted to understand each molecule that plays a role in the 
development of these HIV-associated pathologies, Gelbard and his laboratory have contributed 
research to inventing a new drug that will function adjunctively with cART (combination 
antiretroviral therapy). "Despite continued advances in combination antiretroviral therapy 
(cART) that have turned human immunodeficiency virus-1 (HIV-1) infection into a medically 
manageable disease, HIV-1-associated neurocognitive disorders (HAND) persist, prompting the 
need for adjunctive therapy" (Marker et al., 9998). Their answer was URMC-099, a molecule 
that inhibits the expression of MLK3 in neurons and immune cells of the central nervous system. 
MLK3 is expressed when these cells become stressed, and in the context of HIV infection, marks 
them for destruction by the immune system. In a research article published in 2013, the lab 
reported that their "lead compound, URMC-099, robustly inhibits microglial release of 
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inflammatory mediators and pathologic clearance of synaptic and axonal elements in in vitro and 
in vivo models of HAND" (Marker et. al., 9999). URMC-099 was also able to reduce the 
production of pro-inflammatory cytokines, thus reducing the chance of recruiting more immune 
cells to the brain. However, "it did not normalize the cytokine production to control levels" 
despite normalizing synaptic architecture (Marker et. al., 10010). 
One piece of notable technology used in the Gelbard laboratory is the microfluidic 
chamber. Experiments with the microfluidic chamber are the concept for the interactive game 
developed as part of this Thesis project. The microfluidic chamber is a small, sterile, rectangular 
polymer with four holes connected by two channels; a smaller channel connects the larger 
channels. A solution of hippocampal neuronal cells from a rat are loaded in one side (2 wells) of 
the chamber and those neurons are allowed three days to grow across the barrier into the 
apposing wells. The empty wells are filled with a solution containing microglia and other 
reagents and proteins; these include saline solution (as the control), URMC-099, and Tat protein. 
This technology is useful in observing how different chemical environments affect the 
relationship between microglia and neurons. It was this method that the laboratory used to 
determine whether the URMC-099 molecule's "reduction in cytokine release and phagocytosis 
would potentially have a neuroprotective effect" (Marker et. al., 10010). 
An important piece of technology used by the laboratory for imaging their experiments 
was the University of Rochester's two-photon fluorescence light microscope. "Two-photon 
fluorescence microscopy allows three-dimensional imaging of biological specimens in vivo… it 
offers the advantages of deeper tissue penetration and less photo damage" (So, 1). The photons 
were important in exciting the fluorescence proteins of marked cells within the hippocampal 
region of mice; green fluorescent protein (GFP) was expressed in microglia, and yellow 
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fluorescent protein (YFP) was expressed in neurons. Some captured images were composited 
into short micrograph animations (gifs), and later incorporated into the animation made for this 
Thesis. With the use of two-photon fluorescent light microscopy, the lab was able to show how 
"infiltrating inflammatory leukocytes engulfed dendritic spines and microglial processes" (Lu, 
2). Another imaging technique used by the lab is immunocytochemistry, a technique where 
marked antibodies specific to neuronal and microglial proteins are traced to detect their target 
antigen. 
This brief summary of Dr. Gelbard's research topics and techniques is still very dense and 
extensive. There was definitely a need for art to help communicate their information and 
interpret the micrographs from their observations. This Thesis represents a necessary relationship 
between art and science. 
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THE BODY OF WORK – OVERVIEW 
The project includes an animation, an interactive game, and a series of illustrations that 
accompany research papers, articles, grant proposals, and presentations for lectures and 
conventions. The purpose of this project is to help interpret the research being conducted in the 
Gelbard research lab to better communicate the pathophysiology and molecular targets that are 
the mechanism for HAND. Most of the visuals previously being used to convey the information 
were micrographs and crude illustrations. Even though micrographs are images of what is 
literally taking place between cells, they are still small, difficult to interpret, and do not direct a 
learner's attention to meet the desired instructional objective. 
 
GOALS OF THE ARTWORK 
The art created for this project have the following objectives: 
• Learners will be able to list the major steps involved in HIV protein's effect on 
microglial activation and ultimate synapse engulfment 
• Learners will be able to identify molecules relevant to HIV infection, such as 
cytokines released by immune cells and a particular HIV protein known as 
transactivator of transcription, or Tat, studied by the lab 
• Learners will be able to compare and contrast various scenarios of 'normal' and 
pathologic 'clinical' conditions 
• Learners will be able to actively learn about one of the lab techniques through use of 
the game; topics covered include the cells studied, equipment involved, and 
observations that are typically expected. 
 
Visualization of HIV-Associated Neurocognitive Disorders 
	  15	  
ILLUSTRATION PROCESS 
 The illustrations all started in a similar fashion: with sketches and notes supplied by the 
lab explaining their needs for a particular figure telling a story from their research. Afterwards, a 
sketch of the actual figure was created and submitted to the lab members for review. Once a 
critique of the illustration was received, edits were made and another draft was submitted. If all 
aspects of the illustration were cleared, then the file was exported in a format suitable for the 
illustration's final use. The important thing to notice is the amount of collaboration between all 
members of the team: the illustrations, although not created by the lab, are reviewed by the lab to 
maintain scientific accuracy. 
 Meetings were held at the University of Rochester to discuss their illustration requests. 
During a typical meeting, as mentioned, sketches and notes were exchanged. Although the 
sketches were very rough, in the sense that they were just generalized shapes of the desired 
characters in the story being told, they were beneficial in seeing what the lab was expecting in 
the illustrated figure. The meetings were also helpful because the science contained within the 
story was explained. Sometimes additional printed lab materials were supplied to gain 
background information on the topic, but most of the science being discussed was both building 
on and pushing previously studied topics in human cellular biology, immunology, and pathology. 
The supplemental printed materials included published papers from the Gelbard lab and 
illustrated figures from other labs; the term illustrated is used lightly here because the simple, 
colored, geometric shapes of the other labs' figures do not compare to the artwork submitted to 
the Gelbard lab through this Thesis. 
 After meeting with the members of the Gelbard lab, a sketch summarizing everything 
discussed was composited and submitted for review. There were a few cases where too much 
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information needed to be crammed into a small illustration. One solution was to pick out the very 
important information and build the illustration around it. The other solution was to avoid cutting 
the amount of information and suggest two separate illustrations, each containing part of the 
desired information. Other scenarios presented themselves where the illustration would be large 
enough to contain all of the information the lab wanted to explain, but it would then be split into 
two separate PowerPoint slides for easy interpretation during presentations. 
 When the artwork was handed over to the Gelbard lab for review, the scientific accuracy 
of the images and labels were checked. Their critiques were usually sent via email, but 
sometimes they were exchanged in person. The extent of the edits varied by project. The lab 
members were very helpful in communicating their edits, both in person and over the internet. 
Again, they generally critiqued the accuracy of the images and text. They did not mind the colors 
chosen, as most were chosen based on medical illustration conventions. Colors for some of the 
cells were chosen based on imaging techniques used by the lab; for example, microglia were 
tagged with green fluorescent protein during experiments, so the cells were rendered as being 
green in the illustrations. 
 Once the edits were made, a final draft was submitted for one final pass. If everything 
about the illustration was deemed acceptable, then the file was exported based on its intended 
use. It was important for the lab to communicate the intended use of the artwork prior to starting 
so the file size and profiles could be properly set up (Image 01). 
 The research lab was very actively involved in the illustration process. Although this 
body of work is a Thesis, it should be viewed more as a collaboration between all parties. 
Without the contribution of the lab members' knowledge, the illustrations here would just be 
strange visuals that lack substance. 
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Published Illustrations: 
Illustration for 
LRRK2 Modulates Neuroinflammation and Neurodegeneration in Models of HIV-1 Associated 
Neurocognitive Disorders, in the Journal of Neuroscience 
Authors: Jenna M. Puccini, Daniel F. Marker, Timothy Fitzgerald, Justin Barbieri, Shao-Ming 
Lu, Harris A. Gelbard 
 
(Image 02) 
 This illustration was designed to show the simplified steps that lead to synapse 
phagocytosis by microglia when in the presence of HIV-1 Tat protein. The steps show the 
microglia morphological changes, antibody release, and the eventual synapse destruction; all 
occurring within the central nervous system. 
 A reference image was supplied by the lab that they have used before explaining all of 
the above steps. The only problem was that their image showed only one step: the final one. It 
was concluded that this single image did not explain everything clearly and that a custom 
illustration was necessary. A sketch was proposed, edited, and finally put into production. 
 Some colors were chosen arbitrarily, while others were already predetermined. Microglia 
were colored green, for reasons mentioned earlier. However, the colors for the HIV-1 Tat protein 
and antibodies were chosen to match the general color scheme of the rest of the illustration. 
 The illustration was organized in a hierarchy that was two-fold: one that showed the steps 
from top to bottom, and another that was centered on large microglia in the center of the 
illustration. The hierarchy of the steps is pretty obvious; the events would happen sequentially 
down the marked path. The microglia in the center, although part of the path, has its own sub-
steps associated with it to suggest that this is where a lot of the action takes place. 
 Micrographs from the lab's experiments helped show the nature of microglia extensions 
and relative size between all of the cells being studied. The shape of various molecules used in 
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the artwork was researched to ensure accuracy. Most molecules were found in the Protein Data 
Bank; codes made available through the website were then used by UCSF Chimera to gain a 3-
dimensional representation of the molecule. A screenshot was captured in the program and 
placed in Adobe Illustrator to be traced and filled. The style used to render the molecules was 
inspired by David Goodsell of the The Scripps Research Institute and the RCSB PDB (Image 
03). 
Illustration for 
PAF: Presynaptic and Postsynaptic Mechanisms of Injury in HAND 
Co-sponsored by National Institutes of Mental Health and Allergy and Infectious Diseases 
Author: Jennetta Hammond 
 
(Image 04) 
 
 This illustration was created to visualize the proposed research that describes varying 
concentrations of neurotransmitters in presynaptic neurons. Before this research, it was just 
assumed that neurotransmitters were evenly distributed throughout the neuron or at least higher 
in concentration closer to the synapse. The research suggests otherwise, that there are three 
different areas of varying concentrations. 
 Again, the goal of the illustration was to show the different concentrations of 
neurotransmitters in a neuron. This was achieved in two ways: one way was to represent the 
vesicles as spheres dispersed throughout the neuron, and the other way are the bands of colors 
overlap the neuron to clearly define each area. If this wasn't enough, each area was designated a 
letter so it could be referred to in supporting text. 
 Initially, this illustration was meant to couple another one describing how vesicles are 
moved from within the neuron to the active zone of the presynaptic neuron. It was suggested that 
this was way too much information to cram into one illustration, and was later broken into the 
two separate ones, although this illustration was the only one to be included in the grant proposal 
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(Image 05). 
 The color of the neuron is based on standards in the medical illustration field, although 
YFP (yellow fluorescent protein) is used in the lab’s microscopy studies to image the neurons. 
The colors of the neurotransmitters were arbitrary, although cooler colors were chosen to make 
them easily distinguishable under the layers of colors for the neuron and vesicles. 
All of the illustrations created for the Thesis, whether they were made for print or just 
PowerPoint presentation, were all approached the same way; with meetings to propose ideas and 
gather references, submissions of sketches, reviews of the sketches, and final production. The 
important thing to notice is the amount of collaboration between all members of the team: the 
illustrations, although not created by the lab, are reviewed by the lab members to maintain 
scientific accuracy. 
 
ANIMATION PROCESS 
 The animation was approached in a methodical way: discussions were held to brainstorm 
ideas, a script and storyboard were created to outline the story, models were created and 
animated, and the animation was finally composited by adding titles, labels, and scene 
transitions. Similar to the illustration process, the animation was created as a collaboration; the 
art was created on one end, while the content was being fact-checked on the other. The animation 
was created to help explain a concept in an entertaining medium, so maintaining scientific 
accuracy was key. 
 The discussions were held at the University of Rochester in the lab, as well as online via 
email. Email just made communicating faster and easier, so questions could be answered as they 
arose and reference files could be shared. A brief description of what the animation was going to 
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describe was sent for interpretation and reference. The description was brief and was left open 
for much interpretation. 
 The reference materials sent via email were short gifs made from several micrographs 
taken during observations. The composited images were made by a former lab member named 
Jin Qi. The movies showed the general landscape of the brain at a cellular level: microglia and 
neurons could be seen scattered around the outside of blood vessels.  Monocytes were seen 
rolling through the blood vessels, and only a few were caught passing through the thin 
endothelial wall to encounter surrounding brain tissue. These videos were extremely helpful in 
visualizing the relationship between all of the characters in the story being told. 
 A script was conceived from the brief summary initially sent and a storyboard was drawn 
up along side of it. The script was written first to help set up scenes for the animation. Sketches 
were made and the storyboard was laid out for review. The storyboard allowed the lab to put the 
script into context and to get a feel for how the information would be communicated through this 
medium; it was key to keep the images clear and simple enough for people to grasp the 
information quickly if presented during conventions. 
 After the script and storyboard were reviewed and edits were made to both, a final review 
of the material was conducted. Then models of the characters and environment were made in 
Autodesk Maya, a 3D modeling and animating program. The animation was made using 
Autodesk Maya, and later composited in Adobe After Effects so titles, labels, and sounds could 
be added. The final file was exported and sent to the lab so they may use it. The animation was 
also uploaded to Vimeo so the public may view it and to make the video more accessible for the 
lab members (Image 06). 
 The animation was created with the help of the Gelbard research lab to maintain scientific 
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accuracy. This project within the Thesis should also be considered a collaboration because of the 
input from all members. With the lab member’s support, this animation becomes more than just a 
mere visual, but rather a teaching tool. 
Animation Decisions: 
 Several artistic decisions were made; such as color, lighting, and layout, but the layout 
and flow of the scenes were collaborated on between all members of the thesis committee. Some 
of the decisions were made using conventions in the medical illustration field. The animation 
portion of the Thesis was a culmination of several software programs and techniques learned 
through the program’s coursework. 
 Color was chosen based on each graphic element; certain aspects were kept muted to 
direct the viewer’s attention to the main character being discussed. For example, the background 
color was a muted neutral color so the vibrant colors of the characters would cause them to stand 
out and catch the viewer’s attention. There was a molecule generated in Maxon Cinema 4D from 
its code found online; colors were assigned to each element based on color conventions 
established by chemists (Image 07). White blood cells were shown to be a hue between blue and 
green to pay homage to their staining and fluorescent characteristics. 
 The toon-shader was primarily used in Autodesk Maya to render the 3-dimensional 
characters, while the 2-dimensional art was made in Adobe Illustrator. This decision was made 
to make the contrast between the 2-dimensional and 3-dimensional art a little less obvious. 2-
dimensional art was used to simplify some of the concepts discussed. The 3-dimensional art was 
necessary in representing and interpreting micrographs supplied by the lab. 
 Some artistic license was used for lighting, and throughout the entire Thesis. As it is the 
convention of medical illustrators, the main light came from the upper left corner of each scene. 
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A 3-point lighting set-up was used to illuminate objects from all around, but the strength of each 
light was adjusted to allow some areas to be darker to maintain the appearance of a 3-
dimensional shape. However, any light seen in micrographs comes from the activated fluorescent 
proteins within the tagged cells. 
 Decisions about shapes were easy to make; micrographs from the lab and other resources 
defined all of the shapes needed, so little interpretation was necessary. Micrographs taken 
directly from the mice and other histology references helped in building the cellular and 
environmental elements (Image 08). The molecular model came from information available on 
the Protein Data Bank. 
 The dimension of the animation was kept small. The dimensions, 640 pixels wide by 480 
pixels high, were chosen for easy placement within presentations. The smaller dimensions also 
made the file size smaller. Together, this decision would not over burden the researchers’ files 
when placing the animation into a presentation or referencing the Vimeo file online. 
Most of the artistic decisions came from pre-existing methods for visualizing the cells 
and their environments, while others were direct interpretations from other resources. Colors and 
lighting were some of the attributes that have already been defined within the profession. 
Specific shapes and details about cellular and molecular shapes were defined by very specific 
resources; it was important to maintain these shapes to continue the goal of scientific accuracy 
throughout the Thesis. 
 
GAME CREATION PROCESS 
 The interactive piece of the Thesis was designed to be a teaching tool, in a game format 
that was both engaging and easy to understand. In general, the area of their research, that this 
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game covers, studies the specific interactions between microglia and neurons in different 
chemical environments using the microfluidic chamber (Image 09). These experiments are 
necessary for determining molecules, like URMC-099, that may be neuroprotective. The 
microfluidic chamber was useful in isolating the cells in chambers, as the name suggests, and the 
game design aimed at replicating this set-up. Instead of trying to imagine how these experiments 
were conducted, this game was created to introduce the topic in an entertaining way. 
 The suggestion for an additional piece to add to the Thesis was last minute, but well 
received. The primary investigator of the lab was very excited about the idea and only stated that 
the game should be centered on the microfluidic chamber. Brainstorming began to occur almost 
instantly and a new conversation about a microfluidic chamber game began. Another researcher 
from the lab joined the conversation and supplied some specific information to include in the 
game. One of the research papers read over the summer contained some of the information that 
the original content was based on. Email exchanges occurred several times to critique the game 
and maintain accuracy of the information discussed; mainly regarding the chemicals added to the 
microglia chamber and effects of the chemical on the cells.  
 The game was created in Adobe Flash CC, and the artwork was created in Adobe 
Illustrator. The version of Adobe Flash matters because this version allows the user to create 
their file as an HTML5 canvas. In other words, instead of generating ActionScript as the 
exported code, Flash would create an HTML5 and JavaScript document. This is important 
because HTML5 and JavaScript are supported by many or all devices, unlike ActionScript. 
Unfortunately, the HTML5 canvas is unable to perform all of the actions that ActionScript code 
can, so this had to be put into consideration when planning the actual gameplay. Once the game 
was completed and exported, it was hosted from my personal portfolio website for easy access. 
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The lab was happy with this arrangement because they would not have to purchase a domain 
name and a web hosting service for themselves. 
Decisions about the Game Creation: 
 As with the other components of this body of work, most colors and shapes were 
predetermined by medical illustration industry standards. However, imaging studies performed 
by the lab influenced the colors. For example, microglia were represented as green cells because 
of the presence of GFP. 
 The end result of the game was not the first design to be proposed. Although each design 
was centered on the same concept of adding chemicals to a well in the chamber, the method of 
doing so had varied. One idea involved simply pushing a button in a row of buttons, each with a 
corresponding chemical mixture. Once pushed, a pipette would come down and inject the 
mixture into the well. This idea was scrapped when comparing the actual sizes of the well and 
pipette tip; the well is extremely small and the pipette tip would dominate the screen when the 
injection occurs. A draft of the design with a smaller pipette tip was made, but quickly discarded 
again due to its inaccuracy. (Image 10) The other half of the game, actually clicking on the cells 
within the well, never changed. 
 It was decided to make the game have two levels, considering how much information 
there was to cover. On the first page, the user sets up the cellular components of their wells. Text 
on the side of the screen informed the user as to the actual cellular mixture used in the lab; this 
was considered the first layer of information when discussing what is studied with a microfluidic 
chamber. The action of setting up the wells was a simple drag-and-drop interactivity. This 
method was perceived as more user engaging. 
 Drag-and-drop interactivity is fun, but the user might expect something else to happen 
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once the item is dropped; typically, this is a small animation. The decision was made to simulate 
how a fluid would spread when dropped into a container (Image 11). Shape tweens and clipping 
masks were used in Adobe Flash to create this look on the first page. 
 The researchers stressed the importance of the growth period neurons are allowed 
between being placed in the chamber well, and the time when the observations are made. Extra 
animations would have been too costly on internet bandwidth, so this next layer of information 
was presented in a panel that briefly discussed it. This panel, off screen in the Flash file, moves 
onto the screen when the player moves from the first page to the second page, to suggest time 
had passed between the two stages (Image 12). 
 Finally on the last page, the user can conclude the experiments by adding chemicals to 
the well containing the microglia. Normally, the chemicals and microglia are already mixed 
before being added to the well, but this may have been too much information at once for a user 
just learning about this experiment method for the first time. Again, this game is a tool for 
opening a discussion between labs in an interesting fashion. Chemicals were added using drag-
and-drop interactivity. The well contained a highlighted microglia that, when clicked on, would 
present the user with a small panel that discussed how the added chemical would make the 
microglia interact with a neuron (Image 13). 
 The style of the illustrations was kept simple because the information presented was so 
dense. Although the illustration style was flat-vector, the game did not come across as being 
immature; this was very important considering the audience that would potentially be using it. 
Since there was a lot of information to discuss and only so much space to show it, the 
presentation of the information had to be creative and well planned. The idea was to have large 
images with bits of information that would be snuck into the game, so the user would not be 
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turned off by the idea of learning. 
The decisions made for this game were well planned and influenced by a lot of factors: 
imagery standards of the medical illustration field, lots of information and ideas from the 
researchers, and overall human-computer interaction concepts. Since this game presented so 
much information, it was decided to break the game up into different layers, each concentrating 
on different information. As with the rest of the Thesis, communication between everyone was 
important in maintaining scientific accuracy of the game. 
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CONCLUSION 
 This body of work was successful in many ways; not only did it achieve the goals that 
were originally outlined in the beginning of this document, but it was also an invaluable learning 
experience for someone entering the medical illustration profession. The time and effort put into 
each project was definitely well spent, as the work was well received by the lab members and 
knowledge of different computer programs was gained. Even though the amount of work 
completed was fruitful, there are still opportunities to further the work. 
 The lessons learned include communicating with clients, reading and interpreting dense 
research papers, and creating digital artwork for various outputs. Through communicating with 
the client, the information from the research articles was broken down into key components that 
would be important for creating illustrations. Communicating with the lab members included in-
person meetings and email conversations; each exchange had to be concise in order to make the 
most out of everyone’s time. Aside from learning much about the business and creation ends of 
the field, it was a great education about the current state of HIV research, too. 
 It was apparent that the work had completed the original goals based on the lab’s positive 
reception of each project. The lab members were pleased to see their worked visualized (on the 
macroscopic level), and made good use of the illustrations by including them in their written 
work. The publications include an article in the Journal of Neuroscience and grant proposal 
(grant number: 1 F32 MH105288-01). An illustration was also used in a lecture on the lab’s 
campus, and again at the Society of Neuroscience convention. 
 This work definitely has the potential to be continued further. More illustrations could be 
made for the lab’s publications; when considering how prolific the lab’s members are at 
generating publications, there must always be an opportunity to create the illustrations to 
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accompany them. One animation is definitely not enough to summarize all that they do, too. 
Unfortunately, time and financial constraints are always a factor and the potential abundance of 
work will be cut short. 
It was a great experience working with this lab; they are a great group of people that are 
always open to explaining their work and who appreciate the amount of time and personal 
research that goes into the artwork supplied to them. Both parties of this relationship benefited 
from sharing their knowledge and talents, and the friendly, professional atmosphere made the 
experience very enjoyable. It is sad to conclude this work, but this adventure is hopefully just the 
start of more opportunities to create art that has a purpose in the scientific research and 
healthcare communities. 
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GLOSSARY 
Astrocyte - "a type of glial cell in the brain 
major functions include holding the neurons in 
proper spatial relationship, inducing the brain 
capillaries to form tight junctions important in 
the blood-brain barrier, and enhancing 
synaptic activity" (Sherwood, G-2) 
 
Blood-brain barrier (BBB) - "special 
structural and functional features of the brain 
capillaries that limit access of materials from 
the blood into the brain tissue" (Sherwood, G-
3) 
 
cART - combined antiretroviral therapy; 
"antiviral therapy in which several antiviral 
drugs are used together to try and avoid the 
rapid generation of mutant viruses resistant to 
one of the drugs alone" (Parham, G:6) 
 
Dementia - "cognitive decline that can be 
caused by any disorder that permanently 
damages large areas of the cerebral 
hemispheres or subcortical areas subserving 
me more and learning" (Porth, 1378) 
 
Epidemic - "outbreak of infectious disease 
that affects many individuals within a 
population" (Parham, G:8) 
 
GFP - green fluorescent protein; marker of 
gene expression and protein targeting in intact 
cells and organisms 
 
Hippocampus - "the elongated, medial 
portion of the temporal lobe that is a part of 
the limbic system and is especially crucial for 
forming long-term memories" (Sherwood, G-
7) 
 
HAND - HIV-associated neurocognitive 
disorder; condition defined by neurocognitive 
damage inadvertently / indirectly caused by 
HIV presence throughout the nervous system, 
but primarily in the brain;  "syndrome of 
cognitive impairment with motor dysfunction 
or behavioral/psychosocial symptoms 
associated with HIV infection itself" (Porth, 
436) 
 
HIV - human immunodeficiency virus; "a 
retrovirus that selectively attacks the CD4+ 
T-lymphocytes, the immune cells responsible 
for orchestrating and coordinating the immune 
response to infection" (Porth, 428) 
 
Immunocytochemistry - "The study of cell 
constituents by immunologic methods, such as 
the use of fluorescent antibodies" (Medical-
Dictionary.theFreeDictionary.com) 
 
In vitro - "outside the living body and in an 
artificial environment" (Merriam-
Webster.com)  
 
In vivo - "in the living body of a plant or 
animal" (Merriam-Webster.com) 
 
Kinase - "any of various enzymes that 
catalyze the transfer of phosphate groups from 
a high-energy phosphate-containing molecule 
(as ATP) to a substrate" (Merriam-
Webster.com) 
 
Leukocyte - "general term for a white blood 
cell. Lymphocytes, granulocytes, and 
monocytes are all leukocytes" (Parham, G:13) 
 
Microglia - "the type of glial cells that serve 
as the immune defense cells of the CNS" 
(Sherwood, G-9) 
 
MLK3 - mixed-lineage kinase type 3, or 
MAP3K11, "is expressed in neurons and CNS 
immune effector cells and is activated by 
cellular and metabolic stress" (Marker, 9999) 
 
Monocyte - "type of white blood cell that 
leaves the blood and sets up residence as a 
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front-line defense agent in various tissues" 
(Sherwood, 138). 
 
Neurocognitive disorder - or 
neurodegenerative disorder,  "A chronic 
progressive neuropathy characterized by 
selective and generally symmetrical loss of 
neurons in motor, sensory, or cognitive 
systems" (Medical-
Dictionary.theFreeDictionary.com) 
 
Neuroglia - or glial cells, cells within the 
CNS that are not neurons (Sherwood, 135) 
 
Neuroinflammation - inflammation of the 
central nervous system 
 
Neuroprotective effect - effect of a drug "to 
interfere with the calcium cascade and thus 
reduce brain cell injury" (Porth, 1302) 
 
Opportunistic infection - "infections that 
occur as the immune system becomes severely 
compromised" and function is impaired; "they 
are categorized by the type of organism 
(fungal, protozoal, bacterial and 
mycobacterial, viral)"  (Porth, 433) 
 
Retrovirus - "RNA virus that replicates via a 
DNA intermediate that inserts into the host 
cell chromosome" (Parham, G:18) 
 
Synapse - "the specialized junction between 
two neurons where an action potential in the 
presynaptic neuron influences the membrane 
potential of the postsynaptic neuron, typically 
by releasing a chemical messenger that 
diffuses across the small cleft between the 
neurons" (Sherwood, G-14) 
 
Tat - transactivator of transcriptase; HIV-1 
protein that activates transcription of its 
genome (Lu et al., 1) 
 
URMC-099 - a new MLK3 inhibitor 
molecule; research with this molecule 
suggests that it may have neuroprotective 
capabilities (Marker et. al., 9999)  
 
YFP - yellow fluorescent protein; marker of 
gene expression and protein targeting in intact 
cells and organisms 
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